Cephalon Will Not Seek Gabitril Anxiety Indication In The Near-Term
This article was originally published in The Pink Sheet Daily
Executive Summary
Phase III trial evaluating tiagabine for treatment of generalized anxiety disorder did not meet primary endpoints.